LEXX
NASDAQ · Pharmaceuticals
Lexaria Bioscience Corp
$0.62
-0.02 (-3.01%)
Open$0.65
Previous Close$0.64
Day High$0.65
Day Low$0.60
52W High$1.55
52W Low$0.46
Volume—
Avg Volume209.1K
Market Cap15.88M
P/E Ratio—
EPS$-0.48
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+4,153.3% upside
Current
$0.62
$0.62
Target
$26.43
$26.43
$20.55
$26.43 avg
$40.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.00M | 718.1K | 9.47M |
| Net Income | -16,901,051 | -10,903,122 | 1.90M |
| Profit Margin | -1,686.0% | -1,601.7% | 20.1% |
| EBITDA | -16,745,152 | -11,402,691 | 3.60M |
| Free Cash Flow | — | — | 1.11M |
| Rev Growth | +39.5% | +39.5% | +1.1% |
| Debt/Equity | — | — | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |